1246616-73-8
中文名稱(chēng)
(S)-7-羥基-6,8-二氧-3,4,6,8,12,12A-六氫-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷
英文名稱(chēng)
(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid
CAS
1246616-73-8
分子式
C13H14N2O6
分子量
294.26
MOL 文件
1246616-73-8.mol
更新日期
2024/03/08 11:55:41
1246616-73-8 結(jié)構(gòu)式
基本信息
中文別名
多替拉韋雜質(zhì)9度魯特韋雜質(zhì)F
度魯特韋中間體2
(S)-7-羥基-6,8-二氧-3,4,6,8,12,12A-六氫-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷
(4R,12AS)-3,4,6,8,12,12A-六氫-7-羥基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]惡嗪-9-羧酸
英文別名
Dolutegravir Impurity FDolutegravir Intermediate2
Doultegravir 4-F Impurity G
Dolutegravir Intermediates1
Doultegravir Imp F(Tri cyclic impurity)
(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1...
(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-c
(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid
(4R,12aS)-7-Hydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid
(4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid
應(yīng)用領(lǐng)域
用途一
(4R,12As)-7-Hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic Acid is an intermediate used in the synthesis of Defluoro Dolutegravir (D228715), which is an impurity of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.